Observational research presented in March 2026 at the American Academy of Orthopaedic Surgeons annual meeting found that GLP-1 drugs may slightly increase the risk of developing osteoporosis and gout, a kind of inflammatory arthritis caused by a buildup of uric acid
Clinical implication The updated FDA labeling for liraglutide and semaglutide highlights the importance of monitoring depressive symptoms or suicidal thoughts, suggesting treatment discontinuation if such ideations occur [87,88]
Market research helps determine launch strategies, price points, and outreach efforts
At PatchAid, we support total health
whats more, when we visited the page with a US IP address, we received a Browser Guard warning: The site tried to redirect me to a known Phishing domain while sending some information in the URL which might be used to identify which of the targets clicked the link
Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (2017)